Lv63
2300 积分 2023-08-28 加入
C5aR1 inhibition reprograms tumor associated macrophages and reverses PARP inhibitor resistance in breast cancer
1个月前
已完结
Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer
1个月前
已完结
Blocking CX3CR1+ Tumor-associated Macrophages Enhances the Efficacy of Anti-PD-1 Therapy in Hepatocellular Carcinoma
1个月前
已完结
CDK9 inhibitors for the treatment of solid tumors
2个月前
已完结
Targeting cyclin-dependent kinase 9 in cancer therapy
2个月前
已完结
Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy
3个月前
已完结
Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments
3个月前
已完结
Predicting and overcoming resistance to CDK9 inhibitors for cancer therapy
3个月前
已完结
Discovery of AZD4573, a Potent and Selective Inhibitor of CDK9 That Enables Short Duration of Target Engagement for the Treatment of Hematological Malignancies
3个月前
已完结
Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments
4个月前
已完结
皖公网安备34019202002308
